GLYBURIDE

N/A

Manufactured by Cadila Pharmaceuticals Limited

52,941 FDA adverse event reports analyzed

Last updated: 2026-04-14

About GLYBURIDE

GLYBURIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Cadila Pharmaceuticals Limited. The most commonly reported adverse reactions for GLYBURIDE include BLOOD GLUCOSE INCREASED, NAUSEA, WEIGHT DECREASED, DRUG INEFFECTIVE, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLYBURIDE.

Top Adverse Reactions

BLOOD GLUCOSE INCREASED3,038 reports
NAUSEA2,016 reports
WEIGHT DECREASED1,535 reports
DRUG INEFFECTIVE1,400 reports
DIARRHOEA1,282 reports
DIZZINESS1,200 reports
HYPOGLYCAEMIA1,170 reports
BLOOD GLUCOSE DECREASED1,163 reports
FATIGUE1,147 reports
DYSPNOEA1,094 reports
ASTHENIA1,046 reports
VOMITING1,021 reports
PAIN947 reports
MYOCARDIAL INFARCTION894 reports
DECREASED APPETITE890 reports
HEADACHE846 reports
RENAL FAILURE752 reports
FALL730 reports
CARDIAC FAILURE CONGESTIVE694 reports
MALAISE654 reports
PAIN IN EXTREMITY654 reports
ARTHRALGIA606 reports
PNEUMONIA598 reports
OEDEMA PERIPHERAL595 reports
CHEST PAIN563 reports
DEATH550 reports
WEIGHT INCREASED547 reports
ANXIETY545 reports
CEREBROVASCULAR ACCIDENT523 reports
HYPERTENSION515 reports
PRURITUS502 reports
DIABETES MELLITUS499 reports
RASH495 reports
OFF LABEL USE490 reports
ANAEMIA485 reports
COUGH481 reports
INSOMNIA480 reports
TREMOR478 reports
BACK PAIN477 reports
CHRONIC KIDNEY DISEASE475 reports
HYPOTENSION467 reports
BLOOD PRESSURE INCREASED456 reports
ACUTE KIDNEY INJURY448 reports
CONSTIPATION443 reports
INJECTION SITE PAIN443 reports
FEELING ABNORMAL439 reports
ABDOMINAL PAIN UPPER435 reports
HYPERHIDROSIS429 reports
DEPRESSION423 reports
ABDOMINAL PAIN416 reports
CORONARY ARTERY DISEASE408 reports
PYREXIA405 reports
RENAL FAILURE ACUTE404 reports
CONFUSIONAL STATE403 reports
DEHYDRATION401 reports
GAIT DISTURBANCE398 reports
GLYCOSYLATED HAEMOGLOBIN INCREASED388 reports
DYSPEPSIA366 reports
ATRIAL FIBRILLATION359 reports
DRUG INTERACTION359 reports
URINARY TRACT INFECTION338 reports
SOMNOLENCE334 reports
CONDITION AGGRAVATED332 reports
MYALGIA332 reports
HYPERGLYCAEMIA328 reports
MUSCLE SPASMS325 reports
NASOPHARYNGITIS324 reports
VISION BLURRED315 reports
ABDOMINAL DISTENSION314 reports
LOSS OF CONSCIOUSNESS306 reports
INCORRECT DOSE ADMINISTERED302 reports
BLOOD CREATININE INCREASED295 reports
HAEMOGLOBIN DECREASED289 reports
SYNCOPE289 reports
DIABETES MELLITUS INADEQUATE CONTROL285 reports
DRUG DOSE OMISSION272 reports
GASTROOESOPHAGEAL REFLUX DISEASE268 reports
HEART RATE INCREASED268 reports
MUSCULAR WEAKNESS259 reports
CARDIAC DISORDER257 reports
HYPOAESTHESIA254 reports
GASTROINTESTINAL HAEMORRHAGE252 reports
PANCREATITIS247 reports
RENAL IMPAIRMENT243 reports
DRUG EFFECT DECREASED239 reports
ERYTHEMA236 reports
TYPE 2 DIABETES MELLITUS232 reports
SEPSIS230 reports
JOINT SWELLING228 reports
ABDOMINAL DISCOMFORT225 reports
FLUSHING225 reports
CARDIAC ARREST224 reports
CHILLS224 reports
PARAESTHESIA224 reports
INJECTION SITE BRUISING217 reports
INJURY217 reports
INJECTION SITE HAEMORRHAGE210 reports
URTICARIA208 reports
RESPIRATORY FAILURE207 reports
CATARACT200 reports

Report Outcomes

Out of 23,893 classified reports for GLYBURIDE:

Serious 62.7%Non-Serious 37.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male11,921 (51.6%)
Female11,131 (48.2%)
Unknown40 (0.2%)

Reports by Age

Age 68638 reports
Age 65599 reports
Age 64548 reports
Age 70547 reports
Age 59522 reports
Age 66515 reports
Age 63512 reports
Age 62505 reports
Age 61490 reports
Age 67485 reports
Age 60473 reports
Age 69473 reports
Age 72462 reports
Age 71459 reports
Age 58452 reports
Age 74447 reports
Age 76417 reports
Age 75413 reports
Age 57406 reports
Age 73405 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLYBURIDE?

This profile reflects 52,941 FDA FAERS reports that mention GLYBURIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLYBURIDE?

Frequently reported terms in FAERS include BLOOD GLUCOSE INCREASED, NAUSEA, WEIGHT DECREASED, DRUG INEFFECTIVE, DIARRHOEA, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLYBURIDE?

Labeling and FAERS entries often list Cadila Pharmaceuticals Limited in connection with GLYBURIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.